Artiva Biotherapeutics (ARTV) Assets (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Assets of $106.0 million for Q1 2026, down 44.6% year-over-year from $191.3 million in Q1 2025, and down 19.08% quarter-over-quarter from $130.9 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Assets (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Assets for 4 consecutive years, with $106.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 44.6% year-over-year to $106.0 million; the TTM figure through Mar 2026 stood at $106.0 million (down 44.6% YoY), while the FY2025 annual figure was $130.9 million, down 37.52% from the prior year.
- Assets retreated to $106.0 million in Q1 2026 per ARTV's latest filing, from $130.9 million in the prior quarter.
- Across five years, Assets topped out at $225.6 million in Q3 2024 and bottomed at $75.9 million in Q2 2024.
- Historically, Assets has averaged $151.4 million across 4 years, with a median of $148.9 million in 2025.
- Annual changes were most pronounced in 2025 — Assets jumped 123.14% — and 2026, when it slumped 44.6%.
- Artiva Biotherapeutics' Assets stood at $105.1 million in 2023, then jumped by 99.38% to $209.6 million in 2024, then sank by 37.52% to $130.9 million in 2025, then decreased by 19.08% to $106.0 million in 2026.
- Business Quant data shows ARTV's Assets at $106.0 million in Q1 2026, $130.9 million in Q4 2025, and $148.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 368.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 368.63 Mn |
| Mar 31, 2026 | 105.96 Mn |
| Dec 31, 2025 | 130.94 Mn |
| Sep 30, 2025 | 148.86 Mn |
| Jun 30, 2025 | 169.39 Mn |
| Mar 31, 2025 | 191.26 Mn |
| Dec 31, 2024 | 209.58 Mn |
| Sep 30, 2024 | 225.60 Mn |
| Jun 30, 2024 | 75.91 Mn |
| Dec 31, 2023 | 105.11 Mn |